DENITA PEELE-WHICKUM: Open Payments
NPI 1265137434 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 39 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $456 · 2025 $801
Food & beverage: $689Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $175 |
| Teva Pharmaceuticals USA, Inc. | 6 | $167 |
| Neurocrine BioSciences, Inc. | 8 | $150 |
| Alkermes, Inc. | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 1 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| TMS NeuroHealth Centers Inc. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, SPRAVATO, TRINTELLIX, ARISTADA, COBENFY, AUSTEDO XR, UZEDY.
Industry payments across VA — which companies pay providers there.
